Abstract
SummaryThe role of gender and menopause in obstructive sleep apnoea is well known; however, no study has reported the impact of gender on the clinical presentation and the nocturnal respiratory events in patients with obesity hypoventilation syndrome. Therefore, this study prospectively evaluated differences in the clinical characteristics of women and men with obesity hypoventilation syndrome in a large cohort of patients with obstructive sleep apnoea. During the study period, a total of 1973 patients were referred to the sleep clinic with clinical suspicion of obstructive sleep apnoea. All patients underwent overnight polysomnography, during which time spirometry, arterial blood samples and thyroid tests were routinely obtained. Among 1973 consecutive patients, 1693 (617 women) were diagnosed with obstructive sleep apnoea, among whom 144 suffered from obesity hypoventilation syndrome (96 women). The prevalence of obesity hypoventilation syndrome among women and men was 15.6% and 4.5%, respectively (P < 0.001). Women with obesity hypoventilation syndrome were significantly older than men with obesity hypoventilation syndrome (61.5 ± 11.9 years versus 49.1 ± 12.5 years, P < 0.001). Although there were no significant differences between genders regarding symptoms, body mass index, spirometric data or daytime PaCO2, women with obesity hypoventilation syndrome suffered significantly more from hypertension, diabetes and hypothyroidism. The prevalence of obesity hypoventilation syndrome was higher in post‐menopausal (21%) compared with pre‐menopausal (5.3%) women (P < 0001). HCO3 and duration of SpO2 <90% were the only independent predictors of obesity hypoventilation syndrome. In conclusion, this study reported that among subjects referred to the sleep disorders clinic for evaluation of obstructive sleep apnoea, obesity hypoventilation syndrome is more prevalent in women than men, and that women with obesity hypoventilation syndrome suffer from significantly more co‐morbidities. Post‐menopausal women with obstructive sleep apnoea have the highest prevalence of obesity hypoventilation syndrome.
Topics

No keywords indexed for this article. Browse by subject →

References
38
[1]
AASM American Academy of Sleep Medicine (2014)
[6]
Anttalainen U. "Short‐term medroxyprogesterone acetate in postmenopausal women with sleep‐disordered breathing: a placebo‐controlled, randomized, double‐blind, parallel‐group study" Menopause (2014) 10.1097/gme.0000000000000130
[12]
Berry R. B. Brooks R. Gamaldo C. E.et al.The AASM Manual for the Scoring of Sleep and Associated Events: Rules Terminology and Technical Specifications Version 2.1.American Academy of Sleep Medicine Darien Illinois 2014.www.aasmnet.org.
[15]
Eichling P. S. "Menopause related sleep disorders" J. Clin. Sleep Med. (2005) 10.5664/jcsm.26347
[16]
Gharibeh T. "Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options" Nat. Sci. Sleep (2010)
[24]
Standardisation of spirometry

M. R. Miller, J. Hankinson, V. Brusasco et al.

European Respiratory Journal 10.1183/09031936.05.00034805
[29]
Regensteiner J. G. "Combined effects of female hormones and metabolic rate on ventilatory drives in women" J. Appl. Physiol. (1989) 10.1152/jappl.1989.66.2.808
[34]
White D. P. "Hypoxic ventilatory response during sleep in normal premenopausal women" Am. Rev. Respir. Dis. (1982)
[35]
WHO World Health Organization.Waist Circumference and Waist‐Hip Ratio. Report of a WHO Expert Consultation 8–11 December Geneva.World Health Organization Geneva 2011.
Metrics
56
Citations
38
References
Details
Published
Mar 18, 2016
Vol/Issue
25(4)
Pages
445-453
License
View
Funding
Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia
Cite This Article
Ahmed S. BaHammam, Seithikurippu R. Pandi‐Perumal, Amanda J. Piper, et al. (2016). Gender differences in patients with obesity hypoventilation syndrome. Journal of Sleep Research, 25(4), 445-453. https://doi.org/10.1111/jsr.12400